Learn more about the newly launched Omega-3 Index Project at Engredea/Natural Products Expo West
March 2, 2017, Oslo, Norway: Omega-3 deficiency is a global issue, putting people at higher risk of chronic disease, and education is essential in eliciting positive change. To that end, Aker BioMarine is officially rolling out a new platform called The Omega-3 Index Project™ to help bring more awareness to omega-3 EPA/DHA insufficiency, which affects most consumers worldwide. After a successful launch in Australia, the Aker BioMarine team is making waves in the U.S. market and is excited to share this Project with Engredea/Natural Products Expo West attendees. All are invited to visit Aker BioMarine’s booth (#775) to learn more about The Omega-3 Index Project and get their levels tested onsite with Dr. Bill Harris, an internationally recognized omega-3 expert and co-inventor of the Omega-3 Index Test.
Created in collaboration with Dr. Harris, The Omega-3 Index Project provides tools that will help consumers and health practitioners alike, identify, correct and maintain healthy levels of omega-3s EPA/DHA. The cornerstone of the Project is the Omega-3 Index Test, which is a simple nutritional tool that measures the amount of EPA and DHA in red blood cells. Learn more about the Project here: http://www.omega3indexproject.com/us/
“This project is unlike any other initiative in the omega-3 industry. We are creating awareness of omega-3 deficiency, which consumers must acknowledge and act on in order to create positive change,” said Dr. Harris. “In the near future, I believe this tool will be equally important to a cholesterol test. The difference is the approach to correcting a negative Omega-3 Index score (i.e., low EPA/DHA level) is simply to consume more of the right omega-3s, like EPA and DHA. The Omega-3 Index Project will bring value to the industry in many ways and this is just the beginning.”
Visit Aker BioMarine’s Booth #775 during Engredea/Natural Products Expo West 2017 to:
Get your omega-3 EPA/DHA levels tested at the Aker Booth (#775) with Dr. Bill Harris and learn more about The Omega-3 Index Project. Testing will take place all three days of the show.
Hear more about Aker BioMarine’s newest products—Superba™ 2 and Superba™ Boost—and how they can raise the Omega-3 Index, as well as inspire new product launches and line extensions.
Learn more about a clinical trial we are running with the US Army Rangers and the other exciting studies we have planned for the future.
For more information please contact:
Marketing & Communications Director, Superba™
About Aker BioMarine
Aker BioMarine is a biotech innovator and Antarctic krill fishing company dedicated to improving human and planetary health. The company develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill fishing in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. Aker BioMarine is fully owned by Aker ASA, an industrial pioneer since its establishment in 1841.
About Superba™ Krill
Superba™ Krill is a pure, natural source of the health-promoting EPA & DHA omega-3 essential fatty acids and the naturally occurring antioxidant astaxanthin. The uniqueness of Superba™ Krill is that the omega-3 fatty acids are provided in phospholipid form. In vitro, in vivo and human clinical research has demonstrated the safety and efficacy of Superba™ Krill.